Live Breaking News & Updates on Capella Imaging

Stay updated with breaking news from Capella imaging. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NorthStar Medical Radioisotopes Advances Focus on Therapeutic and Specialized SPECT Radiopharmaceuticals


NorthStar Medical Radioisotopes Advances Focus on Therapeutic and Specialized SPECT Radiopharmaceuticals
NorthStar poised to be first commercial-scale supplier of important therapeutic radioisotopes Copper-67 (Cu-67) and Actinium-225 (Ac-225); Initial specialized SPECT imaging portfolio includes fibrin-targeted FibroScint, with potential indications in cardiovascular disease
March 16, 2021   NorthStar Medical Radioisotopes, LLC announced organizational changes to drive focused growth for its therapeutic and specialized single photon emission computed tomography (SPECT) radioisotopes business. The new structure enables NorthStar to advance its efforts in radioisotope development and commercialization planning in parallel with its ongoing expansion programs for increased U.S. molybdenum-99 (Mo-99) capacity and production.
In conjunction with other organizational changes, NorthStar has appointed Dave Wilson, RPh., BCNP, as Vice President, Advanced Radiopharmaceutical an ....

United States , University Of Missouri , Dave Wilson , Stephen Merrick , Capella Imaging Inc , University Of Missouri Research Reactor , Operations For The Company , Northstar Medical Radioisotopes , Vice President , Advanced Radiopharmaceutical , Commercial Operations , Capella Imaging , Investigational New Drug , Chief Executive Officer , Northstar Medical , Radiogenix System , Radiogenix System Produced , Accelerator Production , Missouri Research Reactor , ஒன்றுபட்டது மாநிலங்களில் , மிச Ou ரி , பல்கலைக்கழகம் ஆஃப் மிச Ou ரி , டேவ் வில்சன் , ஸ்டீபன் மெரிக் , கேப்பேல்ல இமேஜிங் இன்க் , பல்கலைக்கழகம் ஆஃப் மிச Ou ரி ஆராய்ச்சி ரியாக்டர் ,